Details for New Drug Application (NDA): 017573
✉ Email this page to a colleague
The generic ingredient in VANCERIL is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
Summary for 017573
Tradename: | VANCERIL |
Applicant: | Schering |
Ingredient: | beclomethasone dipropionate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;INHALATION | Strength | 0.042MG/INH | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 017573
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | VANCERIL | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 017573-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Schering | VANCERIL | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 017573-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Schering | VANCERIL | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 017573-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription